Mesenchymal stromal cell therapy in COPD: from bench to bedside

By | 2018-07-16T13:32:12+00:00 July 16th, 2018|COPD, Mesenchymal Stem Cells|Comments Off on Mesenchymal stromal cell therapy in COPD: from bench to bedside

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defies COPD as a “common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflw limitation that is due to airway and/or alveolar abnormalities usually caused by signifiant exposure to noxious particles or gases”.

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/MSCs-in-Tx-of-COPD-Oct-2017.pdf” title=”MSC’s in Tx of COPD Oct 2017″]

About the Author: